Arthrex, Inc., a leading innovator in the field of orthopaedic surgery, is headquartered in the United States, with significant operations across North America, Europe, and Asia. Founded in 1981, the company has established itself as a pioneer in minimally invasive surgical solutions, focusing on areas such as sports medicine, joint reconstruction, and trauma. Arthrex is renowned for its advanced surgical instruments and implants, which are designed to enhance patient outcomes and streamline surgical procedures. The company’s commitment to education and training for healthcare professionals further distinguishes it in the industry. With numerous patents and a strong market presence, Arthrex continues to set benchmarks in orthopaedic innovation, making it a trusted name among surgeons worldwide.
How does Arthrex, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Arthrex, Inc.'s score of 12 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2020, Arthrex, Inc. reported total emissions of approximately 175,000 kg CO2e, primarily from gas usage, with no emissions reported from Scope 1, 2, or 3 categories. This figure represents a slight increase from 2019, when emissions were about 148,000 kg CO2e, and a decrease from 2018, which saw emissions of approximately 160,000 kg CO2e. Despite these figures, Arthrex has not disclosed any specific reduction targets or initiatives as part of their climate commitments. There are no climate pledges or SBTi (Science Based Targets initiative) targets reported, indicating a lack of formalised strategies for emissions reduction at this time. The emissions data is not cascaded from any parent organisation, and all figures are sourced directly from Arthrex, Inc. As the company continues to navigate its environmental impact, further transparency and commitment to reduction strategies may be beneficial for aligning with industry standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arthrex, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
